Geschlechtsspezifische Aspekte bei interstitiellen Lungenerkrankungen

Katharina Buschulte, Markus Polke

Tóm tắt

Từ khóa


Tài liệu tham khảo

Valeyre D, Duchemann B, Annesi-Maesano I et al (2014) Interstitial lung diseases. In: Welte T, Annesi-Maesano I, Viegi G, Lundbäck B (Hrsg) Respiratory Epidemiology, Bd. 65. ERSMonograph,

American Thoracic Society and European Respiratory Society (2002) American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 165(2):277–304

Travis WD, Costabel U, Hansell D (2013) An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 188(6):733–748

Kawano-Dourado L, Glassberg MK, Johannson KA et al (2021) Sex and gender in interstitial lung diseases. Eur Respir Rev 30(162):210105

Karampitsakos T, Papaioannou O, Tzouvelekis A et al (2021) Interstitial Lung Diseases and the Impact of Gender. Clin Chest Med 42(3):531–541

Izbicki G, Segel MJ, Breuer R et al (2002) Time course of bleomycin-induced lung fibrosis. Int J Exp Pathol 83(3):111–119

Sclafani A, VanderLaan P (2018) Lymphangioleiomyomatosis. N Engl J Med 378(23):2224

Borie R, Crestani B, Bichat H (2009) Prevalence of telomere shortening in familial and sporadic pulmonary fibrosis is increased in men. Am J Respir Crit Care Med 179(11):1073

Wälscher J, Witt S, Kreuter M et al (2020) Hospitalisation patterns of patients with interstitial lung disease in the light of comorbidities and medical treatment—a German claims data analysis. Respir Res 21(1):73

Dempsey TM, Payne S, Limper AH et al (2021) Adoption of the antifibrotic medications pirfenidone and nintedanib for patients with idiopathic pulmonary fibrosis. Ann Am Thorac Soc 18(7):1121–1128

Tannenbaum C, Ellis RP, Schiebinger L et al (2019) Sex and gender analysis improves science and engineering. Nature 575(7781):137–146

Fuentes N, Silveyra P (2018) Endocrine regulation of lung disease and inflammation. Exp Biol Med (Maywood) 243(17–18):1313–1322

Tzouvelekis A, Bouros D (2019) Estrogen Signaling and MicroRNAs in Lung Fibrosis. Sex, Hormones, and Rock Scars. Am J Respir Crit Care Med 200(10):1199–1200

Newton CA, Batra K, Garcia CK et al (2016) Telomere-related lung fibrosis is diagnostically heterogeneous but uniformly progressive. Eur Respir J 48(6):1710–1720

Zhang D, Adegunsoye A, Newton CA et al (2023) Telomere length and immunosuppression in non-idiopathic pulmonary fibrosis interstitial lung disease. Eur Respir J 62(5):2300441

Knight SW, Heiss NS, Poustka A et al (1999) X‑linked dyskeratosis congenita is predominantly caused by missense mutations in the DKC1 gene. Am J Hum Genet 65(1):50–58

Cronkhite JT, Xing C, Garcia CK et al (2008) Telomere shortening in familial and sporadic pulmonary fibrosis. Am J Respir Crit Care Med 178(7):729–737

Townsley DM, Dumitriu B, Young NS et al (2016) Danazol treatment for telomere diseases. N Engl J Med 374(20):1922–1931

Hoffman TW, van Moorsel CHM, Grutters JC et al (2023) No effect of danazol treatment in patients with advanced idiopathic pulmonary fibrosis. ERJ Open Res 9(5):131–2023

Frontbrune FS, Resche-Rigon M Assistance Publique – Hôpitaux de Paris. https://clinicaltrials.gov/ct2/show/NCT03710356/. Zugegriffen: 01.2024

Reynolds C, Feary J, Cullinan P (2020) Occupational Contributions to Interstitial Lung Disease. Clin Chest Med 41(4):697–707

Kerget B, Araz O, Akgun M et al (2019) Female workers’ silicosis diagnosis delayed due to gender bias. Occup Med (lond) 69(3):219–222

Singh N, Singh S (2021) Interstitial Lung Diseases and Air Pollution: Narrative Review of Literature. Pulm Ther 7(1):89–100

https://www.who.int/news-room/fact-sheets/detail/household-air-pollution-and-health#:~:text=Women%20and%20children%20disproportionately%20bear,from%20polluting%20stoves%20and%20fuels., letzter Abruf 5. Febr. 2024

Gold JA, Jagirdar J, Rom WN et al (2000) Hut lung. A domestically acquired particulate lung disease. Medicine (Baltimore) 79(5):310–317

Hagmeyer L, Randerath W (2015) Smoking-related interstitial lung disease. Dtsch Ärztebl Int 112(4):43–50

Margaritopoulos GA, Vasarmidi E, Antoniou KM et al (2015) Smoking and interstitial lung diseases. Eur Respir Rev 24(137):428–435

Davies G, Wells AU, du Bois RM (2004) Respiratory bronchiolitis associated with interstitial lung disease and desquamative interstitial pneumonia. Clin Chest Med 25(4):717–726

https://www.lung.org/quit-smoking/smoking-facts/impact-of-tobacco-use/women-and-tobacco-use, letzter Aufruf 6. Febr. 2024

Salisbury ML, Xia M, Flaherty KR et al (2016) Idiopathic Pulmonary Fibrosis: Gender-Age-Physiology Index Stage for Predicting Future Lung Function Decline. Chest 149(2):491–498

Hodgson U, Laitinen T, Tukiainen P (2002) Nationwide prevalence of sporadic and familial idiopathic pulmonary fibrosis: evidence of founder effect among multiplex families in Finland. Thorax 57(4):338–342

Zaman T, Moua T, Lee JS et al (2020) Differences in Clinical Characteristics and Outcomes Between Men and Women With Idiopathic Pulmonary Fibrosis: A Multicenter Retrospective Cohort Study. Chest 158(1):245–251

Costabel U, Miyazaki Y, Selman M et al (2020) Hypersensitivity pneumonitis. Nat Rev Dis Primers 6(1):65

Raghu G, Remy-Jardin M, Wilson KC et al (2020) Diagnosis of hypersensitivity pneumonitis in adults. An Official ATS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med 202(3)::e36–e69

Rittig AH, Hilberg O, Løkke A et al (2019) Incidence, comorbidity and survival rate of hypersensitivity pneumonitis: a national population-based study. ERJ Open Res 5(4):259–2018

Fernández Pérez ER, Kong AM, Cole AL et al (2018) Epidemiology of Hypersensitivity Pneumonitis among an insured population in the United States: A Claims-based Cohort Analysis. Ann Am Thorac Soc 15(4):460–469. https://doi.org/10.1513/AnnalsATS.201704-288OC

Blanc PD, Annesi-Maesano I, Redlich CA et al (2019) The occupational burden of nonmalignant respiratory diseases. An Official American Thoracic Society and European Respiratory Society Statement. Am J Respir Crit Care Med 199(11):1312–1334

Tillie-Leblond I, Grenouillet F, Millon L et al (2011) Hypersensitivity pneumonitis and metalworking fluids contaminated by mycobacteria. Eur Respir J 37(3):640–647

Walters GI, Mokhlis JM, Burge PS et al (2019) Characteristics of hypersensitivity pneumonitis diagnosed by interstitial and occupational lung disease multi-disciplinary team consensus. Respir Med 155:19–25

Wijsenbeek M, Cottin V (2020) Spectrum of fibrotic lung diseases. N Engl J Med 383:958–968

Stevenson BR, Thompson GA, McLean-Tooke AP et al (2019) Autoantibodies in interstitial lung diseases. Pathology 51(5):518–523

Kono M, Nakamura Y, Chida K et al (2014) Usual interstitial pneumonia preceding collagen vascular disease: a retrospective case control study of patients initially diagnosed with idiopathic pulmonary fibrosis. PLoS ONE 9(4):e94775

Fairweather D, Frisancho-Kiss S, Rose NR (2008) Sex differences in autoimmune disease from a pathological perspective. Am J Pathol 173:600–609

Shao T, Shi X, Shuai Z et al (2021) Interstitial lung disease in connective tissue disease: A common lesion with Heterogeneous Mechanisms and Treatment Considerations. Front Immunol 7;12:684699 (Jun)

Huang S, Doyle TJ, Sparks JA et al (2020) Rheumatoid arthritis-related lung disease detected on clinical chest computed tomography imaging: Prevalence, risk factors, and impact on mortality. Semin Arthritis Rheum 50(6):1216–1225

Kondoh Y, Makino S, Kuwana M et al (2021) 2020 guide for the diagnosis and treatment of interstitial lung disease associated with connective tissue disease. Respir Investig 59(6):709–740

O’Mahony AM, Lynn E, Murphy DJ, Fabre A, Lymphangioleiomyomatosis MC (2020) a clinical review. Breathe (sheff) 16(2):200007

Aubry MC, Myers JL, Tazelaar HD et al (2000) Pulmonary lymphangioleiomyomatosis in a man. Am J Respir Crit Care Med 162(2 Pt 1):749–752

Schiavina M, Di Scioscio V, D’Errico-Grigioni A et al (2007) Pulmonary lymphangioleiomyomatosis in a karyotypically normal man without tuberous sclerosis complex. Am J Respir Crit Care Med 1;176(1):96–98

Gupta N, Lee HS, Ryu JH et al (2019) The NHLBI LAM registry: prognostic physiologic and radiologic biomarkers emerge from a 15-year prospective longitudinal analysis. Chest 155:288–296

Gupta N, Lee HS, Young LR et al (2019) Analysis of the MILES cohort reveals determinants of disease progression and treatment response in lymphangioleiomyomatosis. Eur Respir J 53:1802066